Sub Categories



Aggrecan (PG) ELISA Kit Maximize

Aggrecan (PG) ELISA Kit

Human Aggrecan (PG) ELISA Kit (MG53281) is an in-vtro immunoassay intended for quantitatively detecting levels of human aggrecan (PG) present in a number of different samples.

More details


96 wells

£ 730.00

Human Aggrecan (PG) ELISA Kit

Specificity : Human
Sensitivity : 0.9ng/ml
Assay Range : 5.3 – 133.0ng/ml
Size: 96 tests

Reagents Supplied:
- Aggrecan/PG Microtiterwells (12x8 break apart strips) [96 wells]
- Aggrecan/PG Standards 0-5 [6 vial lyophilised]
- Diluent Buffer  [2x 30ml]
- Incubation buffer  [11ml]
- Anti-PG-HRP Conjugate  [5.5ml]
- Conjugate Buffer  [2x 11ml]
- Aggrecan/PG Controls [3 vial lyophilised]
- TMB Substrate Solution  [25ml]
- TMB Stop Solution  [25ml]
- Wash Solution [10ml] (200X Concentrated)

Key Features:
[1]. Method:  ELISA
[2]. Kit Size: 96 Wells [12x8].
[3]. Standard Range:  5.3 – 133.0ng/ml
[4]. Incubation Time: 1x 2 h , 1x 30 min , 1x 15 min.
[5]. Substrate: TMB 450nm
[6]. Volume/Specimen: 50μl serum
[7].Regulatory Status:  CE , EU

Intended Use:
Human Aggrecan (PG) ELISA is an enzyme immunoassay designed for quantitative analysis of human aggrecan (PG) in synovial fluid levels in human serum, cell supernatant and synovial fluid.

Expected Values:
(a). Adult sera [age: 16-66 years]: 1-44μg/ml (range) and 2.8μg/ml (mean)
(b). Children sera [age: 3-16 years]: 7-15μg/ml (range) and 10.4μg/ml (mean)

1. Arthritis and Rheumatism (1987) 30 (9): 972-979. Cartilage Proteoglycans in Synovial Fluid and Serum in Patients with Inflammatory Joint Disease. SAXNE T., et al.
2. Litera Rheumatologica, (1991) 13: 33-44. Insulin-Like Growth factor 1 and Glycosaminoglycan-Peptide Complex: Their Effects on Differentiated Human Chondrocytes Cultivated in Clusters. BASSLEER C., HENROTIN Y. and FRANCHIMONT P.
3. The FASEB Journal (1989) 3: 2042-2051. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. HEINEGÅRD D. and OLDBERG A.
4. J. Rheumatol. (1989) 16 (18): 5-9. Effects of Hormones and Drugs on Cartilage Repair. FRANCHIMONT P., BASSLEER C. and HENROTIN Y.
5. Clin. Biochem. (1992) 25: 167-174. Cartilage Matrix Metabolism in Osteoarthritis: Markers in Synovial Fluid, Serum, and urine. LOHMANDER L.S., et al.
6. J. Clin. Invest. (1994) 94: 25-33. Changes in Cartilage Metabolism in Arthritis Are Reflected by Altered Serum and Synovial Fluid Levels of the Cartilage Proteoglycan Aggrecan. POOLE A.R., et al.
7. Litera Rheumatologica (1991) 13: 21-31. Effects of a Glycosaminoglycan-Peptide Complex and Interleukin 1 on Differentiated Human Chondrocytes Cultivated in Clusters. BASSLEER C., HENROTIN Y. and FRANCHIMONT P.
8. J. Rheumatol. (1991) 18 (27): 68-69. Effects of Hormones and Local Growth Factors on Articular Chondrocyte Metabolism. FRANCHIMONT P. and BASSLEER C.
9. Arthritis and Rheumatism (1992) 35 (4): 385-390. Synovial Fluid Analysis of Two Groups of Proteoglycan Epitopes Distinguishes Early and Late cartilage Lesions. SAXNE T. and HEINEGÅRD D.

Special Offers